[L-arginine and nitric oxide have effects on glomerulus hyperperfusion of early diabetic rats]

S Huang1, P Fu, X Li

  • 1Department of Kidney, First Affiliated Hospital, Chengdu.

Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|February 23, 2000
PubMed

Insights

Diabetic kidney disorder appears early, indicated by increased kidney weight and proteinuria. Nitric oxide (NO3-) and L-arginine (L-Arg) may drive early hyperfiltration and hyperperfusion in diabetic nephropathy.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Context:

  • Diabetes mellitus is a complex metabolic disorder with significant renal complications.
  • Early detection of diabetic nephropathy is crucial for effective management.
  • Streptozotocin (STZ)-induced diabetes in rats is a widely used model for studying diabetic kidney disease.

Purpose:

  • To investigate early kidney changes in a rat model of diabetes mellitus.
  • To assess the role of nitric oxide (NO3-) and L-arginine (L-Arg) in early diabetic kidney dysfunction.
  • To correlate changes in NO3- and L-Arg levels with indicators of kidney damage and function.

Summary:

  • STZ-induced diabetes in rats showed increased kidney weight/body weight ratio and proteinuria by day 7, worsening by day 14.
  • Creatinine clearance rate (Ccr) significantly increased, indicating elevated glomerular filtration rate (GFR).
  • Plasma and tissue NO3- levels rose over time and increased further after L-arginine (L-Arg) administration, suggesting their involvement.

Impact:

  • This study highlights early kidney disorder in diabetes, preceding significant functional decline.
  • Findings suggest NO3- and L-Arg play a role in the hyperfiltration and hyperperfusion characteristic of early diabetic nephropathy.
  • Provides insights into potential therapeutic targets for managing early-stage diabetic kidney disease.